BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 33579956)

  • 1. How μ-opioid receptor recognizes fentanyl.
    Vo QN; Mahinthichaichan P; Shen J; Ellis CR
    Nat Commun; 2021 Feb; 12(1):984. PubMed ID: 33579956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How
    Vo QN; Mahinthichaichan P; Shen J; Ellis CR
    bioRxiv; 2020 Nov; ():. PubMed ID: 32839778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How mu-Opioid Receptor Recognizes Fentanyl.
    Vo QN; Mahinthichaichan P; Shen J; Ellis CR
    Res Sq; 2020 Sep; ():. PubMed ID: 32935088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular dynamics of fentanyl bound to μ-opioid receptor.
    Lipiński PFJ; Jarończyk M; Dobrowolski JC; Sadlej J
    J Mol Model; 2019 May; 25(5):144. PubMed ID: 31053968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Affinity, potency, efficacy, selectivity, and molecular modeling of substituted fentanyls at opioid receptors.
    Eshleman AJ; Nagarajan S; Wolfrum KM; Reed JF; Nilsen A; Torralva R; Janowsky A
    Biochem Pharmacol; 2020 Dec; 182():114293. PubMed ID: 33091380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fentanyl-Type Antagonist of the μ-Opioid Receptor: Important Role of Axial Chirality in the Active Conformation.
    Arita H; Tanaka R; Kikukawa S; Tomizawa T; Sakata H; Funada M; Tomiyama K; Hashimoto M; Tasaka T; Tabata H; Nakamura K; Makino K; Oshitari T; Natsugari H; Takahashi H
    J Med Chem; 2024 Jun; 67(12):10447-10463. PubMed ID: 38869493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fentanyl Family at the Mu-Opioid Receptor: Uniform Assessment of Binding and Computational Analysis.
    Lipiński PFJ; Kosson P; Matalińska J; Roszkowski P; Czarnocki Z; Jarończyk M; Misicka A; Dobrowolski JC; Sadlej J
    Molecules; 2019 Feb; 24(4):. PubMed ID: 30791394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homology models of mu-opioid receptor with organic and inorganic cations at conserved aspartates in the second and third transmembrane domains.
    Zhorov BS; Ananthanarayanan VS
    Arch Biochem Biophys; 2000 Mar; 375(1):31-49. PubMed ID: 10683246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural Assessment of Agonist Efficacy in the μ-Opioid Receptor: Morphine and Fentanyl Elicit Different Activation Patterns.
    Ricarte A; Dalton JAR; Giraldo J
    J Chem Inf Model; 2021 Mar; 61(3):1251-1274. PubMed ID: 33448226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steric interactions and the activity of fentanyl analogs at the mu-opioid receptor.
    Dosen-Micovic L; Ivanovic M; Micovic V
    Bioorg Med Chem; 2006 May; 14(9):2887-95. PubMed ID: 16376082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fentanyl and the Fluorinated Fentanyl Derivative NFEPP Elicit Distinct Hydrogen-Bond Dynamics of the Opioid Receptor.
    Lešnik S; Bren U; Domratcheva T; Bondar AN
    J Chem Inf Model; 2023 Aug; 63(15):4732-4748. PubMed ID: 37498626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular docking reveals a novel binding site model for fentanyl at the mu-opioid receptor.
    Subramanian G; Paterlini MG; Portoghese PS; Ferguson DM
    J Med Chem; 2000 Feb; 43(3):381-91. PubMed ID: 10669565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probing biased activation of mu-opioid receptor by the biased agonist PZM21 using all atom molecular dynamics simulation.
    Liao S; Tan K; Floyd C; Bong D; Pino MJ; Wu C
    Life Sci; 2021 Mar; 269():119026. PubMed ID: 33444617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-Kinetics Relationships of Opioids from Metadynamics and Machine Learning Analysis.
    Mahinthichaichan P; Liu R; Vo QN; Ellis CR; Stavitskaya L; Shen J
    J Chem Inf Model; 2023 Apr; 63(7):2196-2206. PubMed ID: 36977188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 'Carba'-carfentanil (trans isomer): a μ opioid receptor (MOR) partial agonist with a distinct binding mode.
    Weltrowska G; Lemieux C; Chung NN; Guo JJ; Wilkes BC; Schiller PW
    Bioorg Med Chem; 2014 Sep; 22(17):4581-6. PubMed ID: 25129170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness comparisons of G-protein biased and unbiased mu opioid receptor ligands in warm water tail-withdrawal and drug discrimination in male and female rats.
    Schwienteck KL; Faunce KE; Rice KC; Obeng S; Zhang Y; Blough BE; Grim TW; Negus SS; Banks ML
    Neuropharmacology; 2019 May; 150():200-209. PubMed ID: 30660628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-Based Approach for the Prediction of Mu-opioid Binding Affinity of Unclassified Designer Fentanyl-Like Molecules.
    Floresta G; Rescifina A; Abbate V
    Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31083294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of morphine analgesic effect with induction of mu-opioid receptor endocytosis in rats.
    Hashimoto T; Saito Y; Yamada K; Hara N; Kirihara Y; Tsuchiya M
    Anesthesiology; 2006 Sep; 105(3):574-80. PubMed ID: 16931992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of μ-opioid receptor activation by acidic pH is dependent on ligand structure and an ionizable amino acid residue.
    Meyer J; Del Vecchio G; Seitz V; Massaly N; Stein C
    Br J Pharmacol; 2019 Dec; 176(23):4510-4520. PubMed ID: 31355457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. To probe interaction of morphine and IBNtxA with 7TM and 6TM variants of the human μ-opioid receptor using all-atom molecular dynamics simulations with an explicit membrane.
    Sader S; Anant K; Wu C
    Phys Chem Chem Phys; 2018 Jan; 20(3):1724-1741. PubMed ID: 29265141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.